Archives by: Dr.med. Napoleon DeLeon

Dr.med. Napoleon DeLeon

44 Posts 0 comments

About the author

Dr.med. Napoleon DeLeon holds a degree in medicine from the United Arab Emirates College, Al Ain, UAE. With over 15 years of experience, he is an expert in evaluating and curating healthcare web content based on clinical evidence.

Dr.med. Napoleon DeLeon Posts

NanoSphere Health Sciences Retains Gravitas Securities and Grant Options

NanoSphere Health Sciences Retains Gravitas Securities and Grant Options
DENVER – Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has retained the services of Gravitas Securities Inc. (“Gravitas”) to act as financial advisors to the ...
Read more 0

Letter from Our Chairman

Letter from Our Chairman
Dear Valued Shareholders, I would like to take this opportunity to outline the details of a significant milestone for NanoSphere Health Sciences and how this will impact the ...
Read more 0

NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen

NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen
NEW CAMPAIGN AIMS TO EDUCATE ATHLETES ON MARIJUANA HEALING POTENTIAL DENVER (July 16, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the biotech firm behind the groundbreaking NanoSphere Delivery System™, ...
Read more 0

Nanotechnology + Cannabis: Why We Need A Delivery System

Nanotechnology + Cannabis: Why We Need A Delivery System
Cannabinoids are NOT User Friendly  Within the cannabis plant there are at least 480 distinct compounds.  Among those at least 111 have been identified as phytocannabinoids and another 111 ...
Read more 0

NanoSphere Health Sciences Inc. Increases Capacity at Key Colorado Production Facility

NanoSphere Health Sciences Inc. Increases Capacity at Key Colorado Production Facility
Demand for the Company’s Groundbreaking Transdermal Evolve NanoSerum™ Driving Production DENVER, Feb. 5, 2018 /PRNewswire/ — NanoSphere Health Sciences Inc. (CSE: NSHS, “NanoSphere”) is pleased to announce that, in response ...
Read more 0

Evolve Formula’s NanoSerum™ Wins the 2017 Dope Cup Award for Best Transdermal

Evolve Formula’s NanoSerum™ Wins the 2017 Dope Cup Award for Best Transdermal
On August 20th, Evolve’s NanoSerum™ won the 2017 Dope Cup award from Dope Magazine for best transdermal. Dope Magazine is distributed in every dispensary in Colorado, Arizona, California, Oregon, Washington, and Nevada. This is a very ...
Read more 0

Nanosphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line

Nanosphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line
DENVER (November 16, 2018)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) is pleased to announce a non-brokered private placement of up to CAD $2,250,000. The proceeds will ...
Read more 0

Nano-Technology Brings Precision to Cannabis

Nano-Technology Brings Precision to Cannabis
With unlimited potential in the emerging cannabis industry, many companies outside the industry are starting to take notice and make a huge impact on product innovation. NanoSphere Health ...
Read more 0

NanoSphere Health Sciences Wins Prestigious Frost & Sullivan 2018 Technology Innovation Award

NanoSphere Health Sciences Wins Prestigious Frost & Sullivan 2018 Technology Innovation Award
NANO-BIOTECHNOLOGY FIRM RECOGNIZED FOR ITS NEXT-GENERATION MEDICAL DELIVERY SYSTEM IN THE FROST & SULLIVAN 2018 BEST PRACTICES AWARDS DENVER (May 23, 2018) – NanoSphere Health Sciences INC (CSE: NSHS) (OTC: ...
Read more 0

Pharmaceutical & OTC

Pharmaceutical & OTC
  NanoSphere Health Sciences provides a revolutionary biocompatible, versatile delivery method for a broad range of pharmaceuticals and over-the-counter medications. Our patented “NanoSphere NSAIDS” will be the first ...
Read more 0